Advertisement

Topics

Lumināt Company Profile

19:05 EST 16th December 2018 | BioPortfolio


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

The order of multiple excited state proton transfer in ternary complex of norharmane and acetic acids.

Dolores Reyman et al. found the norharmane (9H-pyrido [3,4-b] indole) (NHM) and two acetic acid molecules can form the ternary complex (NHM-2A) in component solvent of dichloromethane and acetic acid ...

NK-4 exerts selective regulatory effects on the activation and function of allergy-related Th2 cells.

NK-4 is the main component of the antiallergic drug Lumin, which has been in popular usage since the early 1950s. In this study, we examined whether NK-4 exerts a regulatory effect on the activation a...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Lumināt

Padilla Speer Beardsley

PSB is a national, independent, employee-owned multi-specialty firm focused on comprehensive communication programs for organizations motivated to leverage reputation as a competitive advantage. PSB h...

More Information about "Lumināt" on BioPortfolio

We have published hundreds of Lumināt news stories on BioPortfolio along with dozens of Lumināt Clinical Trials and PubMed Articles about Lumināt for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lumināt Companies in our database. You can also find out about relevant Lumināt Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record